Quick Answer
Mirum Pharmaceuticals, Inc. reported Total Assets of $842.81 million for fiscal year 2025.
Mirum Pharmaceuticals, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $842.81M | +25.7% |
| 2024 | $670.75M | +3.7% |
| 2023 | $646.62M | +83.2% |
| 2022 | $352.91M | +19.8% |
| 2021 | $294.65M | +22.3% |
| 2020 | $240.86M | +64.2% |
| 2019 | $146.71M | +182.3% |
| 2018 | $51.98M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $785.12M | +17.6% | +8.2% |
| June 30, 2025 | $725.83M | +9.8% | +5.2% |
| March 31, 2025 | $690.25M | +5.9% | +2.9% |
| December 31, 2024 | $670.75M | +3.7% | +0.4% |
| September 30, 2024 | $667.89M | +2.7% | +1.1% |
| June 30, 2024 | $660.75M | +49.0% | +1.3% |
| March 31, 2024 | $651.96M | +95.5% | +0.8% |
| December 31, 2023 | $646.62M | +83.2% | -0.6% |
- Mirum Pharmaceuticals, Inc. showed an increase of +25.7% in Total Assets compared to the prior fiscal year.
- Over the 2018–2025 period, Mirum Pharmaceuticals, Inc.’s total assets has grown by 1521.6% (from $51.98 million to $842.81 million).
- The most recent figure is from Mirum Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: